Table 8.
Colon | Experimental group | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period | Con | DSS | BE | Cuo | To | Ro | |||||||
Gene | MW | SEM | MW | SEM | MW | SEM | MW | SEM | MW | SEM | MW | SEM | |
Phase 1 | 1.00 | 0.53 | — | — | 0.56 | 0.10 | 1.04 | 0.10 | 0.56 | 0.21 | 1.17 | 0.70 | |
NFκB | Phase 2 | 1.00 | 0.20 | 1.03 | 0.30 | 0.36 | 0.02 | 1.00 | 0.44 | 2.21 | 1.37 | 0.51 | 0.10 |
Phase 3 | 1.00a | 0.07 | 3.05b | 1.23 | 1.52ab | 0.28 | 1.31ab | 0.30 | 1.09ab | 0.16 | 1.51ab | 0.42 | |
Phase 1 | 1.00 | 0.45 | — | — | 0.31 | 0.05 | 0.38 | 0.12 | 0.42 | 0.15 | 0.41 | 0.14 | |
TNFα | Phase 2 | 1.00a | 0.15 | 3.96ab | 1.48 | 3.84ab | 1.28 | 1.65ab | 0.59 | 4.72b | 1.49 | 2.98ab | 0.76 |
Phase 3 | 1.00a | 0.18 | 3.71b | 0.85 | 4.56b | 0.97 | 3.75b | 0.78 | 4.18b | 1.08 | 3.34b | 0.90 | |
Phase 1 | 1.00 | 0.81 | — | — | 0.13 | 0.03 | 0.90 | 0.40 | 0.55 | 0.29 | 0.96 | 0.61 | |
COX2 | Phase 2 | 1.00ac | 0.35 | 17.7b | 10.26 | 2.43ac | 1.00 | 1.68ac | 0.71 | 3.59bc | 1.10 | 1.25ac | 0.42 |
Phase 3 | 1.00 | 0.17 | 1.31 | 0.55 | 1.41 | 0.34 | 0.87 | 0.27 | 1.10 | 0.33 | 1.00 | 0.21 | |
Phase 1 | 1.00 | 0.10 | — | — | 1.48 | 0.52 | 1.72 | 0.45 | 1.01 | 0.41 | 1.60 | 0.52 | |
IL-1β | Phase 2 | 1.00 | 0.33 | 1.10 | 0.34 | 1.70 | 0.82 | 1.21 | 0.36 | 0.52 | 0.22 | 1.17 | 0.29 |
Phase 3 | 1.00a | 0.33 | 4.69b | 1.40 | 2.32ab | 0.53 | 0.96a | 0.22 | 2.26a | 1.01 | 1.77a | 1.02 | |
Phase 1 | 1.00 | 0.43 | — | — | 2.14 | 1.46 | 1.95 | 0.58 | 2.31 | 1.28 | 2.23 | 1.04 | |
IL-10 | Phase 2 | 1.00a | 0.39 | 1.23ab | 0.35 | 1.46ab | 0.31 | 2.79b | 0.65 | 22.5b | 15.03 | 3.79c | 1.50 |
Phase 3 | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | |||||||
Phase 1 | 1.00 | 0.12 | — | — | 0.88 | 0.09 | 0.94 | 0.04 | 1.46 | 0.45 | 1.04 | 0.23 | |
MCP-1 | Phase 2 | 1.00a | 0.22 | 1.51ab | 0.20 | 2.20b | 0.30 | 1.67b | 0.15 | 2.76b | 0.56 | 2.03b | 0.58 |
Phase 3 | 1.00a | 0.27 | 2.60bc | 0.47 | 3.54b | 0.98 | 1.10a | 0.23 | 0.86a | 0.26 | 1.67ac | 0.57 | |
Phase 1 | 1.00a | 0.42 | — | — | 0.43ab | 0.06 | 0.34b | 0.10 | 0.41b | 0.14 | 0.38b | 0.21 | |
VCAM-1 | Phase 2 | 1.00ab | 0.46 | 2.40a | 1.18 | 0.39b | 0.19 | 0.39b | 0.13 | 0.62b | 0.25 | 0.66ab | 0.42 |
Phase 3 | 1.00a | 0.35 | 6.21b | 2.20 | 4.56b | 0.53 | 1.97a | 1.14 | 1.61a | 0.79 | 1.07a | 0.53 | |
Phase 1 | 1.00a | 0.31 | — | — | 1.03a | 0.19 | 1.71ab | 0.20 | 1.63ab | 0.14 | 2.37b | 0.75 | |
Cldn3 | Phase 2 | 1.00a | 0.38 | 0.57ab | 0.21 | 0.22b | 0.08 | 0.49ab | 0.22 | 0.25b | 0.21 | 0.25b | 0.07 |
Phase 3 | 1.00a | 0.18 | 1.46ab | 0.34 | 0.92a | 0.06 | 1.07a | 0.12 | 1.98b | 0.36 | 1.24a | 0.30 |